Pathological Complete response to neoadjuvant trastuzumab and pertuzumab therapy is dependent on HER2/CEP17 ratio in HER2-positive breast cancer. Issue 2 (February 2019)

• Record Type: Journal Article
• Authors: Choi, J.; Jeon, C.W.; Kim, A.L.; Jung, S.U.
• Is Part Of: European journal of surgical oncology. Volume 45:Issue 2(2019)
• Page Start: e101
• Publication Date: 2019-02
• Subjects: Oncology -- Periodicals; Cancer -- Surgery -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- surgery -- Periodicals; Cancer -- Chirurgie -- Périodiques; Cancérologie -- Périodiques; Oncologie; Chirurgie (geneeskunde); Electronic journals; Electronic journals -- Sciences; Electronic journals -- Medicine; Electronic journals; 616.994059005
• DOI: 10.1016/j.ejso.2018.10.350
• Languages: English
• ISSNs: 0748-7983